Our lawyers are not currently accepting new Risperdal lawsuits. Curtis Weyant has more than 20 years as a writer, editor, and communicator, publishing on a wide variety of topics, especially in the financial, legal, and medical fields. At ConsumerSafety.org, Curtis managed the day-to-day publication of all content from 2016-2019.
Top-Rated Risperdal Attorneys $8 Billion Won by Arnold & Itkin LLP in a Risperdal Case Arnold & Itkin won an $8 billion verdict against Johnson & Johnson for a client who took Risperdal as a child and developed gynecomastia. We were thrilled to help our client get justice after years of bullying and emotional distress.
In early 2018, a Superior Court of Pennsylvania ruling paved the way for thousands of Risperdal cases in the Philadelphia court to seek punitive damages from Johnson & Johnson. Punitive damages had previously been barred by a 2014 trial court judge.
The most recent case management order indicates that the first group of the recent Risperdal trials will begin in June 2019, with additional trials beginning each month after that through 2020. Depending on how early trials go, Johnson & Johnson may be persuaded to settle claims with the remaining plaintiffs.
$70 Million Risperdal Verdict In July 2016, a Philadelphia jury awarded $70 million to Andrew Yount, a Tennessee teen who blamed the drug for causing him to develop female-size breasts.
If you or a loved one took the antipsychotic drug Risperdal (risperidone) and experienced side effects like male breast growth, you may be entitled to a cash award settlement in a Risperdal lawsuit.
Risperdal can cause young boys to develop female breast tissue—a condition known as gynecomastia. As a result, thousands have filed lawsuits against manufacturer Johnson & Johnson.
Hundreds of young men and boys have filed Risperdal lawsuits seeking compensation from Johnson & Johnson for the pain and suffering they endured after developing gynecomastia. Since the drug first went on the market in 1994, Johnson & Johnson has paid out in excess of $2 billion in penalties and complaints.
Risperdal Lawsuit Update 2022 On November 2021, Johnson & Johnson said it has settled “substantially all” of the lawsuits it faced by thousands of men who claimed that the antipsychotic drug Risperdal caused them to develop male breasts.
Risperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
Yes, risperidone is the generic version of Risperdal and is available in the United States. Are there any major differences between Risperdal and other antipsychotics used to treat Risperdal? Risperdal belongs to the class of medications known as atypical antipsychotics or second generation psychotics.
Risperidone oral tablet is available as both a generic and brand-name drug. Brand name: Risperdal. Risperidone comes as a regular tablet, an orally disintegrating tablet, and an oral solution.
Does Risperdal Cause Gynecomastia? Yes. Studies have linked Risperdal to triggering gynecomastia in young male patients. Researchers believe that Risperdal, while an effective antipsychotic medicine, triggers a hormone imbalance in young boys that causes them to grow large female breasts.
There were 1556 cases of gynecomastia and 15,560 corresponding controls. Current users of risperidone had approximately four times the risk of developing gynecomastia than non-users (RR=3.91, 95% CI=2.01-7.62).
Serious side effects include enlarged breast tissue, obesity, heart problems and diabetes, which lead experts to recommend alternative treatments for children who are stable but experiencing aggression or irritability.
Gynecomastia is often due to an imbalance of testosterone and estrogen hormones. Certain medications and diseases can also cause male breast tissue to swell and get bigger. Enlarged breasts in boys and men often improve without treatment.
While this treatment has shown success for patients suffering from varying conditions, it has also proved to have devastating side effects. O...
While the drug has been used in many adolescent children over the years, researchers have discovered a disturbing link between the use of thi...
In September 2012, Johnson & Johnson came to a quick settlement on the first day of a case involving gynecomastia, which had a jury picked...
The Risperdal lawsuit relates to various lawsuits filed by men and boys (or their families) against Johnson & Johnson along with some of its affiliates alleging that the use of their drug caused the enlargement of male breasts.
Risperdal is an antipsychotic drug prescribed by doctors in an attempt to restore the brain’s normal chemical functions.
Many Risperidone lawsuits, lawsuits for adults, and children allege that the use of the J&J drugs in question leads to the production of prolactin hormones stimulating the development of breasts in men and male children.
Johnson & Johnson states in its 2018 annual report that it is exposed to various product liability lawsuits involving the same and some of its subsidiaries involving various products.
Considering there were approximately 13,400 Risperdal side effect lawsuits around the United States, it is not feasible to list the various settlement amounts claimants may have received or the number of cases that J&J and its subsidiaries were able to successfully defend against.
In addition to the various awards granted by the court or jury, the company Johnson & Johnson has also settled various cases out of court.
The US Department of Justice had filed various criminal and civil investigations against Johnson & Johnson relating to the prescription drugs Risperdal, Invega, and Natrecor.
As of March 2019, more than 6,700 Risperdal lawsuits had been filed in the Philadelphia Complex Litigation Center (CLC), a special Pennsylvania State court designed to handle large-scale civil trials (also known as mass torts). The earliest CLC cases were filed in 2010, and a large group of older cases were settled in 2013.
Department of Justice for off-label Risperdal marketing. The investigation resulted in a $2.2 billion settlement, which included payment of $485 million in criminal fines for violating the False Claims Act.
Risperdal (risperidone) is an atypical antipsychotic drug used primarily to treat schizophrenia, bipolar disorder, and irritability associated with autism. While many studies have demonstrated Risperdal's effectiveness at treating these conditions, the drug can also cause a number of serious side effects.
According to Johnson & Johnson's most recent annual report, the company is still facing about 13,400 Risperdal lawsuits. Approximately half of these are filed in the Philadelphia Complex Litigation Center, with the rest being filed in various other state and federal district courts around the country. Unlike many other drug lawsuits, there is no multidistrict litigation for Risperdal.
The most recent case management order indicates that the first group of the recent Risperdal trials will begin in June 2019, with additional trials beginning each month after that through 2020.
Risperdal was first approved for the treatment of schizophrenia in adults in 1994. At that time, it was not approved by the U.S. Food and Drug Administration (FDA) for use in children or the elderly. Johnson & Johnson tried multiple times in the 1990s to gain approval for these age groups without success.
The $2.2 billion settlement amount included approximately $485 million in fines specifically tied to False Claims Act allegations, although the drug manufacturer did not have to admit guilt as part of the settlement.
Allegations of the illegal marketing of Risperdal between 1993 to 2004 were made by consumer protection regulators in a total of 36 states. Louisiana, Texas, Montana and Massachusetts were among the states.
Other states are considering lawsuits as noted by documents filed by regulators in other states. Risperdal made over $4.5 billion in worldwide sales in 2007. Johnson and Johnson hadn’t set aside any money to pay for Risperdal lawsuits, which is a common practice for large corporations.
It also raised the rates of their cholesterol and triglyceride levels. Some boys who were on Risperdal developed a condition called gynecomastia. This is a disorder in which male breast tissue develops abnormally, to the point that some patients who were later awarded punitive damages even lactated.
Louisiana, Texas, Montana and Massachusetts were among the states. In January of 2002, Johnson & Johnson agreed to settle a Medicaid fraud lawsuit for $158 million. The Risperdal lawsuit claimed the drug was illegally marketed and it was also marketed for “off-label” uses.
Johnson and Johnson agreed to pay $2.2 Billion in criminal and civil fines after being accused by the U.S. Justice Department of illegally marketing the drug Risperdal. The drug company marketed it to older adults, children and developmentally disabled people.
Studies have shown that there is an increased risk of death among elderly patients with dementia, especially for those with Alzheimer’s. One study found that out of 83 elderly patients who had taken Risperdal, 39 of them had died within one year of taking Risperdal.
The drug maker was said to have marketed Risperdal as a way to control patients with dementia in nursing homes and for children with some behavioral disabilities even though Risperdal has serious side effects for people with those conditions.
Taking Legal Action for Risperdal Injuries. Call (888) 493-1629 Now! Since September 2012, lawsuits against Johnson & Johnson have been occurring as victims and their families seek to hold the company accountable for the devastating, and embarrassing effects that this drug has had on their male loved ones.
This includes Risperdal M-Tab (disintegrating tablets) and Risperdal Consta (injectable). Call (888) 493-1629 today to discuss your Risperdal injuries with our attorneys. Let us determine if you have a case.
The patent given to Janssen for risperidone expired in December 2003 and the exclusive marking rights were terminated the following June, allowing for generic companies to begin marking the same product for a lower price. Today, risperidone can be found in tablet forms, oral solutions, and through biweekly injections.
Risperdal, otherwise known as risperidone, is an anti-psychotic drug that was initially approved by the FDA and released in 1994 to treat people who have schizophrenia and bipolar disorders. This product was established by Janssen, a subsidiary company of Johnson & Johnson.
Risperdal, approved by the FDA in 1993, is an antipsychotic medication used to treat the symptoms of schizophrenia in adults and teenagers 13 years and older. Lower dosages of Risperdal are often prescribed to children in the treatment of autism, ADHD, forms of bipolar disorder, obsessive-compulsive disorder, psychotic depression and Tourettes syndrome.
The federal government intervened in the suit and eventually settled the case for $2.2 billion. As a condition of the settlement, the U.S. Department of Justice is requiring that Johnson & Johnson (the makers of Risperdal) admit that the drug causes abnormal breast growth in boys and men.
Risperdal, also known by its generic name, Risperidone, is an antipsychotic medication that was originally approved for use with adults with schizophrenia.
Risperdal can, in fact, be a life-saver for some, but it is not without risk. Risperdal an have serious, life-changing side effects.
It seems as if Johnson & Johnson, as well as sub company, Jansen have seen personal injury claims for Risperdal since the 2010. The allegations, starting in 2005, got the ball rolling for the Risperdal litigation to begin in 2010.
In response to petitions of 11 pharmaceutical corporations, the FDA proposed in June 2014 guidance that would allow drug makers to use conflicting studies that understate risks contained on product labeling in order to promote a drug to the health care profession.
Plaintiffs in Risperdal lawsuits allege, among numerous claims, that they or their minor sons developed gynecomastia, which is the abnormal enlargement of male breast tissue, as a result of using the Janssen Pharmaceuticals antipsychotic medication.
If you or a loved one was injured or you think you may have been injured by taking the pharmaceutical drug, Risperdal, contact our pharmaceutical litigation attorneys for a free and confidential Risperdal case evaluation. Call our Houston office at 713-622-7271 or fill out the contact form below!
In 1993 , The U.S. Food and Drug Administration (FDA) approved the use of Johnson & Johnson and Janssen Pharmaceuticals drug, Risperdal, first approved to treat schizophrenia in adults. The drug makers moved quickly to try to expand the use of the drug to build profits, though risked injuries by seeking approval for multiple disorder uses.
Johnson and Johnson faces thousands of lawsuits from plaintiffs linking injuries like gynecomastia to Risperdal, a popular antipsychotic medication. One recent jury awarded a plaintiff $8 billion in a show of overt disapproval of how the drug company marketed the drug without proper warnings.
There are several side effects associated with taking Risperdal. Risperdal (risperi done) may impair your thinking or reactions. Stop using this medicine and call your doctor at once if you have fever, stiff muscles, confusion, sweating, fast or uneven heartbeats, restless muscle movements in your face, tremors, trouble swallowing, or feel light-headed.
Risperdal has been sold to consumers for more than 20 years. Antipsychotic drugs like Risperdal have been regularly prescribed to patients diagnosed with manic depressive disorder, schizophrenia, and childhood autism.